NAGE
Niagen Bioscience, Inc.
NASDAQ: NAGE · HEALTHCARE · BIOTECHNOLOGY
$3.85
-1.43% today
Updated 2026-06-05
Market cap
$287.52M
P/E ratio
17.19
P/S ratio
2.21x
EPS (TTM)
$0.21
Dividend yield
—
52W range
$4 – $15
Volume
0.9M
Niagen Bioscience, Inc. (NAGE) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.85
12-Month target
$3.62
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 17.19x (capped 25x) · Margin: 14.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.